Holen Sie sich die Stockscreener-App
0.132
1.49%
-0.002
Vorhandelsmarkt:
.13
-0.002
-1.52%
Schlusskurs vom Vortag:
$0.134
Offen:
$0.14
24-Stunden-Volumen:
1.71M
Relative Volume:
0.14
Marktkapitalisierung:
$2.01M
Einnahmen:
$32.31M
Nettoeinkommen (Verlust:
$-6.16M
KGV:
-0.0776
EPS:
-1.7
Netto-Cashflow:
$1.08M
1W Leistung:
+12.53%
1M Leistung:
-25.42%
6M Leistung:
-99.72%
1J Leistung:
-99.48%
1-Tages-Spanne:
$0.1279
$0.1494
1-Wochen-Bereich:
$0.115
$0.1494
52-Wochen-Spanne:
$0.115
$64.80
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Vergleichen Sie UPC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
0.132 | 2.01M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
171.80 | 76.93B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.04 | 47.47B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.37 | 46.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.67 | 16.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.25 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Universe Pharmaceuticals Inc Aktie (UPC) Neueste Nachrichten
UPC’s price-to-book ratio: An indicator of the company’s performance - US Post News
Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum - TipRanks
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 - Investing.com India
Universe Pharmaceuticals stock plunges to 52-week low of $0.14 By Investing.com - Investing.com South Africa
Universe Pharmaceuticals receives notice from Nasdaq related to delayed annual report - MSN
Universe Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa
Universe Pharmaceuticals faces potential Nasdaq delisting - Investing.com India
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - The Manila Times
Universe Pharmaceuticals Faces Nasdaq Delisting Risk Due to Delayed Annual Report - TipRanks
Universe Pharmaceuticals INC Faces Potential Delisting from Nasdaq Due to Delinquent Annual Report Filing - Nasdaq
Will Universe Pharmaceuticals Survive Nasdaq's Latest Delisting Threat? - StockTitan
Looking Into Universe Pharmaceuticals's Recent Short Interest - Benzinga
Promising Chinese Stocks Worth Watching – February 21st - Defense World
Dow Tumbles Over 700 Points; US Services PMI Falls In February - Benzinga
Stock market today: Nuburu surged by 81.61% while Aspire Biopharma Holdings plummented by 44.32% in early trading - Business Upturn
Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Universe Pharmaceuticals Adjourns Shareholder Meeting Indefinitely - TipRanks
Universe Pharmaceuticals Adjourns Extraordinary General Meeting Due to Lack of Quorum - TipRanks
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle - HPBL
Finanzdaten der Universe Pharmaceuticals Inc-Aktie (UPC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.05%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):